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Anesthesia plays a vital role in the maintenance of aquaculture species, where it is
used to minimize stress during complex handling tasks such as transport, assessment, and
harvesting. However, anesthetics have been shown to suppress the innate immune response,
which could impact immunity and increase risk of infection. Tricaine methanesulfonate
(MS-222) and 2-Phenoxyethanol (2-PE) represent two of the most commonly used
anesthetics in aquaculture, with R-(+)-carvone, in the form of carvone-methyl salicylate
(CMS) has recently been proposed as an alternative anesthetic for food fish. These three
anesthetics were used to assess the influence of anesthetics on the immune system of
zebrafish (Danio rerio), a model organism for immunological study. Respiratory burst
assays of the zebrafish kidney leukocytes were used to determine the impact of these
anesthetics on the immune response. All treatments showed a significantly decreased
immunological response, with no statistical differences among treatments. These results
indicate that CMS does not suppress the innate immune response any less than the
anesthetics 2-PE or MS-222. Further investigation is needed to better understand the
influence of CMS impact on a fish’s physiological response to confirm these findings.
1. Introduction
1.1 Anesthetics in Aquaculture

Aquaculture in the United States contributes approximately one billion dollars to the US
economy, with US aquaculture representing less than 1% of the world's aquaculture production
(1). Successful aquaculture depends upon healthy, properly cared for fish, and continuous cost
versus growth analysis to determine profitability. Assessing the health and growth of
aquacultured fishes usually requires anesthesia because fish become highly distressed when
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emersed for examination. Fish are also highly susceptible to stress resulting from more complex
handling events, such as transportation, harvesting, and surgery (2). This stress can in turn lead
to acute immune suppression, physical injury, or death, while in the long term it can result in
reproduction inhibition, growth reduction and an overall decrease in the life-span of the fish (3,
4). Anesthesia is used to reduce the stressfulness events. Chemical anesthesia, such as tricaine
(MS-222), is a common method to altering the physiological conditions by raising the CO2
concentrations or inducing hypothermia may be used to incapacitate the fish (3). An anesthetic’s
effectiveness is determined by how quickly fish reach the desired level of anesthesia, the rate the
fish are revived, the mortality rate, and the amount of anesthetic required to achieve the desired
level of anesthesia (3). The cost of the anesthetic must also be taken into consideration, as
aquaculture is an industry.
In addition to considering the general aspects of anesthesia, different handling
circumstances require varying levels and durations of anesthesia. For example, transportation
requires no more than sedation of the fish, which can be achieved by either hypothermia or light
anesthetics, or a combination of the two. This allows the fish to remain calm, and prevents the
fish from settling to the bottom, crowding, and asphyxiating (3). Handling for emersion or
surgery usually requires a much deeper level of anesthesia, both to prevent undue stresses to the
fish and to also allow for ease of handling. However, prolonged exposure or improper dosing at
high levels of anesthesia may kill the fish. Effective anesthetics also need to suppress the
hypothalamo-pituitary-interrenal (HPI) axis. The HPI organs responsible for controlling a
number of hormones, including cortisol. Cortisol is an anti-inflammatory and responsible for
suppressing the innate immune response. If the HPI axis is not suppressed this will result in
increased stress levels even when the fish receives anesthesia, as these organs continue to release
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stress hormones (5). The size, activity level, metabolism, and gill-body mass ratio of the fish
must all be taken into consideration when determining the optimal anesthetic and dosage. Larger
fish, those with a low activity level or low gill to body mass ratios often require larger dosages
to achieve anesthesia (2). Water chemistry and physical characteristics , such as lower
temperatures and alterations of the pH, affect fish anesthesia (2, 3). These conditions vary from
anesthetic to anesthetic, as they can increase the solubility of the anesthetic, serve as a secondary
form of anesthesia, or reduce the efficacy of the anesthetic.
There are legal complications that must also be considered when determining which
anesthetics may be used. Fish that are to be used for human food face tight restrictions so
consumers do not ingest the metabolized anesthetics. The problem with these metabolites is twofold. First, the use of these anesthetics may alter the quality of the fish, potentially providing
consumers with food that is inferior or contains unknown compounds (3). Second, these
metabolites may prove a health risk, and therefore are regulated to protect consumers. Currently,
only MS-222, CO2, and hypothermia are approved means of anesthesia for food fish, with MS222 requiring a 21 day withdrawal period before the fish can be harvested for food products (3,
5).
Though anesthesia is used to reduce stress and prevent complications such as immunesuppression and death, applying anesthetics can result in similar physiological conditions to
handling stress. These complications can vary, depending on both the level of anesthesia
achieved and the type of anesthetic. For example, 2-PE reduces the effect of crowding stress
when used to induce sedation in gilthead seabream (Sparus aurata L.), yet results in an increased
negative immunological response if surgical anesthesia is induced under similar conditions(6).
Tricaine MS-222 does not impede the HPI, allowing for stress hormones, such as cortisol, to
5/17/2011
12:19:54

4

still be expressed under heavy anesthesia, yet it does not result in significant immune
suppression (5, 7). The stress and immune suppression that can accompany anesthesia can result
in an increased risk of infection, especially in the case of surgery, which potentially creates a
vector for infection.
1.2 Tricaine methanesulfonate
Tricaine methanesulfonate (MS-222) is a commonly used anesthetic in aquaculture,
especially as it is the only anesthetic legal for food fish in the United States. It is technically
categorized as a local anesthetic; however, it is primarily used as a general anesthetic in
aquaculture. Anesthesia is achieved by adding MS-222 in proper concentrations to the anesthetic
bath to be absorbed by the skin and gills of the fish, though some form of buffering is usually
required to prevent a significant reduction in the solution pH (3, 8). The rate of anesthesia and
revival are directly linked to the dose administered, as are the chances of side effects (2, 8).
Tricaine methansuflonate increases the risk of hypoxia and acidosis and does not decrease the
basal levels of blood cortisol, since MS-222 does not inhibit the HPI (5, 8). This anesthetic is
excreted through both the gills and urine, with non-metabolized MS-222 and polar metabolites
filtered by the kidney; MS-222 is usually undetectable eight hours after administration (3, 8).
Like other local anesthetics such as benzocaine, it acts by blocking Na+ channels in neurons,
reducing transmission of action potentials (7).
1.3 2-Phenoxyethanol
2-Phenoxyethanol (2-PE) is a general anesthetic. The active ingredient is ethylene glycol
monophenyl ether when metabolized. Its exact mechanism is currently poorly understood,
though it is one of the most frequently utilized anesthetics after MS-222 (2, 6). However, recent
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research has indicated that it acts by reversibly suppressing N-methyl D-aspartate (NMDA)
receptors (9). Though 2-PE has been shown to suppress the innate immune response, it is an antifungal and antibacterial compound, capable of reducing the risk of infection (2, 3, 6). Though
low in cost, 2-PE carries the risk of inducing neuropsychological disorders in the human handlers
(10).
1.4 Carvone-methyl salicylate (R-(+) carvone)
R-(+)-carvone, or simply carvone, is a monoterpene ketone that acts as a natural
anesthetic. It is an essential oil, and it is derived from Mentha spicata var. crispa lamiaceae and
is commonly used for spearmint flavoring (11). R-(+)-carvone decreases motor activity, and it
significantly reduces the nerve transduction of mice (11, 12). These studies demonstrated that
carvone most likely reversibly inhibits the Na+ channels of nerves, suppressing transduction (12).
Though carvone has not been widely used as an anesthetic in aquaculture, preliminary testing has
shown that it is effective at achieving rapid anesthesia and quick revival (13). However,
carvone’s physiological impact in fish is mostly unknown. This study used R-(+) carvone in the
form of carvone-methyl salicylate (CMS) as an anesthetic.
1.5 Zebrafish (Danio rerio)
The zebrafish is a frequently used model organism in immunology and genomics. The
species is small, very easily maintained, relatively low in cost to acquire, and are an effective
laboratory animal because of their short generational time and the large number offspring
produced during each reproduction cycle (14). Another advantage is that all stages of life can be
readily observed. As the embryo is transparent through the larval stages, internal development is
also readily visible (15, 16). Zebrafish genetics have been well researched, with large portions of
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its genome sequenced and readily available through various databases. Mutagenesis screens have
been utilized both to determine gene functions, and to construct molecular models of other
organisms (15). Zebrafish have the advantage of being similar to many other teleost fish, as well
as other vertebrate species, making it a useful model for many different species (17).
The kidney is the primary immunological and hematopoietic organ of adult zebrafish.
The head kidney portion is similar to bone marrow in mammalian species, and acts as the
primary site for hematopoiesis (18). Unlike some other species, where the spleen also acts as a
major site of hematopoiesis, the kidney acts as the sole source of blood and immune response
cells (19). In addition to the creation of immune cells, the kidney also acts as the major site of
the immune response. It is the primary location of non-circulating granulocytes, such as
neutrophils and a cell type that acts as both an eosinophil and basophil (14, 16, 20). The kidney
is also the site of a large number of macrophages and monocytes, and is one of the locations
where T cells may be found in the zebrafish (14).
The neutrophils of zebrafish act in a similar manner to those of mammals (16). Like
mammalian neutrophils, they are granulocytes that primarily destroy infectious agents through
phagocytosis. The actual act of destruction is usually achieved through the release of reactive
oxygen species (ROS) into the vesicle containing the phagocytosed bacteria, along with
hydrolytic enzymes, in a process known as a respiratory burst (17). The production of ROS relies
on phosphorylation of NADPH oxidase, which becomes active and then reduces molecular
oxygen to produce superoxide. The superoxide is then converted to hydrogen peroxide by
superoxide dismutase (21). The superoxide, hydrogen peroxide, and the reactive oxygen species
derivatives of the molecules are then utilized for the respiratory burst (21). Neutrophils can also
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release granules that contain antimicrobial and inflammatory proteins, resulting in further
immune response (16).
1.6 Respiratory Burst Assay
Neutrophils release ROS when they phagocytose a bacterium or cellular debris. This
response can also be triggered by specific chemicals, such as propylene glycol monomethyl ether
acetate (PMA)(22). As the amount of ROS released is an indicator of the health of the innate
immune response, analysis of ROS activity can reveal the influence of environmental factors on
the organism. This analysis relies on fluorescence produced by the oxidation of select materials
by the reactive oxygen species, with stronger fluorescence indicating a more significant innate
immune response (21, 22). This fluorescence is gauged by a microplate reader using light
transmission and optical density measurement at 485 and 530 nm. This allows for multiple
replicates to be measured simultaneously, allowing for an effective comparison of treatments
(21). The comparison of unstimulated and stimulated cells, such as those exposed to bacteria or
PMA, can allow for the exclusion of background ROS release and cell counts, giving an overall
measure of the organism’s health. Because their kidneys are small, zebrafish require the pooling
of kidneys from multiple individuals to achieve sufficient level of fluorescence (22).
1.7 Purpose of the study
Carvone has been investigated as a potential anesthetic in aquaculture, and understanding
its influence on the physiological aspects of fish is important in determining its effectiveness.
Through the use of respiratory burst assays, carvone’s immunological impact can be compared to
MS-222 and 2-PE, and to control samples. This study proposes that carvone may have a lesser
impact on the zebrafish’s innate immune response than MS-222 or 2-PE.
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2. Material and Methods
2.1 Animals
Wild type zebrafish were maintained in community tanks that received a 16:8 light-dark
cycle. They were allowed to acclimate to their tanks for 1 week before any procedures were
performed to eliminate any stress response due to transport. Water temperature was held at 28oC,
and the fish received regular daily feedings. All fish were euthanized with a 0.4 mg/mL MS-222
solution preceding kidney removal (22). Kidney tissue from both male and female fish was used.
All procedures were approved by the Colby College Institutional Animal Care and Use
Committee.
2.2 Anesthetics
The concentrations of anesthetics that were used over the course of the experiment were
determined during preliminary testing to ensure that a 1-hour exposure to the anesthetic could be
achieved in which zebrafish suffered a loss of consciousness followed by recovery (7).
The MS-222 solution was prepared with 0.0161 g of 99.5% pure tricaine
methanesulfonate (Ethyl 3-aminobenzoate methanesulfonate, Sigma-Aldrich E10521, St. Louis,
MO). This was dissolved directly in 200 mL of 28oC aerated water for a 0.0805 mg/mL solution.
This tricaine solution had an average pH of 6.9 at this concentration. The 2-PE solution was
prepared with 65µL of a 99% solution of 2-PE (2-phenyloxyethanol, Sigma-Aldrich 60248 , St.
Louis, MO). This was diluted in 200 mL of 28oC aerated water for a 0.358 mg/mL solution with
an average pH 7.8. The carvone solution was composed of carvone-methyl salicylate (Fisheezzz; Maine Conservation Medicine Center, Waterville, ME). This was then diluted by adding
70µL of the solution to 200 mL of water for a solution with a final concentration of 95.09
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mg/mL of carvone, and had an average pH of 6.9. Solutions were not buffered to minimize
impact of buffering agents on immune system and due to their closeness to physiological pH. A
control group was placed in 200 mL of water that had been aerated and was 28oC, but received
no other treatment.
2.3 Fish Selection and Anesthesia Exposure
For each trial, twelve fish were selected at random from the same community tank. These
fish were immediately transferred to a 2 L tank matching the conditions of the community tank.
A group of three zebrafish was transferred to 200 mL of either one of the anesthetic solutions ,or
200 mL of tank water for a control group. The time of initial exposure was recorded, and the fish
were observed over a 1-hour period to ensure that they were both unconscious and alive (7).
After 1-hour of exposure, the zebrafish were then revived by transferring them to four containers
containing 200 mL of tank water, with each exposure group remaining isolated from the others
(7). If any of the fish did not recover, or died during the one hour period, the procedure would be
repeated and the current group of zebrafish discarded to ensure that there was no interference due
to chemical changes caused by the individual’s death. This was only done on only one occasion,
with the two fish dying due to an overdose of 2-PE. After revival, 20 mL of 4mg/mL MS-222
solution was added to each of 200 mL of water, euthanizing each group (21). Tricaine MS-222
was used to anesthetize all sample groups as it has been indicated in literature to have the lowest
level of suppression of the innate immune system, and to insure that the control group received
the same means of euthanasia as treatment groups.
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2.4 Kidney Extraction and Respiratory Burst Assay
Kidneys were extracted through microdissection of each fish and all kidneys from the
same exposure group were pooled together in 700 mL of DMEM-F12 media (DMEM-F12, Hy
Clone Laboratories, Logan, UT) and kept on ice. Single cell suspensions were produced by
pipette aspiration. Each exposure group was distributed to six different wells on a black 96-well
plate. Each well received 100 µL of cells and 0.1 µg of 3-dichlro-flourescein diacetate (2’,7’dichlorodihydrofluorescein diacetate, Invitrogen, Carlsbad, CA) dissolved in 50µL of DMEMF12. Three wells of each exposure group received the unstimulated control treatment of 50 µl of
DMEM-F12. The remaining three wells of each group received .04 µg of PMA (propylene glycol
monomethyl ether acetate, Sigma-Aldrich, St. Louis, MO) dissolved in 50 µl of DMEM-F12 to
stimulate the cells’ respiratory bursts. Fluorescence was measured on an FLX800TB plate reader
(BioTek) with excitation and emission filters of 485 and 530 nm. The respiratory burst assay was
run for 3.5 hours, with samples taken every 15 minutes (22).
2.6 Data Analysis
The stimulation index (SI) of reactive oxygen species production was determined by
calculating the mean relative fluorescence of the PMA stimulated wells and dividing this by the
unstimulated control wells (22). This was used to indicate the relative level of oxidative bursts
for each exposure groups, and the stimulation index was plotted over time to compare the
different levels of suppression or excitation (22). The unstimulated fluorescence, or background
fluorescence, will be utilized to determine the data validity, with excessively high or low
background fluorescence acting to disqualify results. If the background fluorescence was either
too high or too low, this was an indication of unsatisfactory kidney sample.
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3. Results
3.1 Anesthetics Effects on ROS Levels
The SI was utilized to determine the differences, if any, that existed between the
treatments for the kidney leukocytes. The peaks of the SI plots were utilized as these best
represented the stimulation level of the kidney leukocytes. These peaks were taken from the 90
or 105 minute samplings, which were consistently the highest peaks across all anesthetics and
trials (Fig. 1).
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Figure 1. Mean fluorescence over time.
The mean values of the SI over a 210 minute period, with the fluorescence read at 15 minute intervals. The control
group (♦, R2=0.9972), CMS(▲, R2=0.9962), MS-222 (■, R2=0.9978), and 2-PE(X, R2=0.9969) all showed
maximum peaks at either 90 or 105 minutes. These were determined by H2DCFA fluorescence. n=7.
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The means of the trials were compared (Fig. 2), and statistical analysis by ANOVA
showed that there was a significant difference between the trials (p<0.005). The control group
showed a significantly stronger SI in comparison to the treatments groups. High SI values mean
that the innate immune response of the zebrafish was not as suppressed. Furthermore, the SI for
MS-222 appears to be slightly higher than that of the other two anesthetics. The MS-222
treatment’s SI was 46.48% that of the control, versus the CMS treatment (36.17% of the control
SI) and 2-PE (37.02% of the control SI). However, the difference was not statistically significant
(ANOVA, p > 0.05).
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Figure 2. Comparison of the mean peaks of the control, MS-222, CMS and 2-PE SI
treatment groups. Data represents the means of the peak stimulation indexes at either 90 or 105 minutes with the
appropriate SE bars. n=7. P<0.005, determined by ANOVA test. The control showed a significantly higher SI than
any of the anesthetics, indicative of these cells having a stronger immune response when stimulated.
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3.2 Analysis of Background Fluorescence
The mean background fluorescence was plotted over time to determine if any of the
treatments showed a significantly different fluorescence level, as this could indicate that the
basal levels of expression could have already been elevated. It would also ind
indicate
icate if there were
any fixed patterns of fluorescence levels.

Mean Background Fluorescence
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Figure 3. The mean background
ackground fluorescence over time by treatment groups.
The mean values of the background fluorescence over a 210 minute period, with the fluorescence read at 15 minute
intervals. The control group (♦, R2=0.9972),
.9972), CMS(
CMS(▲, R2=0.9962), MS-222 (■, R2=0.9978), and 2-PE(X,
2
2
R =0.9969)
.9969) all showed a linear fluorescence over time. These were determined by H2DCFA fluorescence. n=7.

Background fluorescence positively and significantly increased over time, and followed a
linear regression for fluorescence increase over the kinetics assay ((Fig. 3).
). The mean background
fluorescence had a near perfect fit (R2 > 0.99). Mean fluorescence indicated that the CMS and
MS-222
222 treatments significantly elevated the background fluorescence in each trial. However,
analysis of the background fluorescence by each trial indicated that there was no significant
difference among the individual treatment
treatments between each round of testing (ANOVA,
ANOVA, P > 0.05)
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(Fig. 4). Comparison of the background fluorescence peaks also indicates a high variability of
the ranges of the data between each trial, with the minimal background fluorescence value of
1,062.67 and a maximum value of 21,183.67 over all of the trials. If the final fluorescence
reading was less than 500 or greater than 25,000, than the sample was likely contaminated and
the results would have been discarded. There also appeared to be a high variability within the
trials themselves, most obvious in trial 6 (fig 4).

25000

Background Fluorescence

20000

15000

Control
Tricaine
Carvone

10000

2-PE
5000

0
Trial 1

Trial 2

Trial 3

Trial 4

Trial 5

Trial 6
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Figure 4. Comparison of raw background fluorescence peaks for the control, CMS, MS222, and 2-PE groups by trial. n=7 for each group. There was no significant difference between the
treatment groups (ANOVA, P >0.05). These are raw data from the trials, compared to determine the basal variance
of the kidney leukocytes fluorescence.

4. Discussion
Anesthesia has been shown to suppress the innate immune response in many different
species, and this was confirmed through analysis of the SI values of the respiratory burst analysis
(Fig. 1) (2, 5-7). A larger SI indicates a much higher active release of ROS in a stimulated state
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in comparison to the basal state of the samples, the results effectively demonstrate that the
control group, which received no anesthesia, had twice the ROS release as the groups treated
with anesthesia (Fig. 1). Furthermore, the data indicate that all of the anesthetics suppress the
innate immune response equally. However, though all suppress the immune response relatively
equally, the mechanisms of the suppression within leukocytes are not necessarily the same and
cannot be determined without further experimentation. Previous literature has indicated that
leukocyte suppression may be caused by the interference with adhesion of leukocytes to target
sites, such as carbohydrate-lectin binding, which could be investigated in future studies (2, 6, 7).
Of interest is the level of the innate immune response suppression by the MS-222
treatment. Though difference in the mean SI values were not statistically different between
treatments, the MS-222 mean SI percent difference was approximately 10% greater than the
other two treatments, with a -53.5% suppression in comparison to a suppression of -63.8% by
CMS and -63% by 2-PE (Fig. 4). Though previous studies indicate that 2-PE suppresses ROS
while MS-222 shows minimal suppression, there may be no actual difference between the effects
of the two anesthetics on the innate immune system (7). However, a larger data sample may
allow for a more clear delineation of the results, and further testing should be pursued to
determine if there is a difference.
The linear regression of the background fluorescence reflects good kidney leukocyte
health and a successful protocol (Fig. 3). As there is no obvious plateau or deviation, this
implies both that the fluorescent H2DCFDA particles do not decrease significantly in
fluorescence after oxidation, and that the cells continue to produce ROS at a relatively constant
rate over the course of the trial. This finding is important, as a constant rate reflects that there is
little cell death during the course of the trial. This would be detected a drop off in the
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fluorescence. There are also no apparent external stimulating factors such as bacterial
contamination, which would be noted by an upturn in the background fluorescence data. Both of
these conditions would indicate a flaw in the experimental methods (20).
The noticeable variation of the background fluorescence among trials could have several
sources (Fig. 4). The first is that the background fluorescence could have been affected by the
amount of cells present, though the SI would not be impacted by the cell counts, as differences in
the amount of cells present in an assay would affect the amount of ROS that could be released
during a time period. As equalization of the cells caused the background fluorescence resulted in
measurements that were too high to be read by the fluorescence reader. It also caused an
exceptionally high variability within the triplicate wells. Thus, the cell concentrations could not
be adjusted. The cell counts should not have affected SI values, as they are excluded by the
calculation, and thus this variation is acceptable for the purpose of the assay. Revision of the
protocol to minimize the variation in the results, which does not result in excessively high
background fluorescence, should be sought in future studies. However, this variance did not
seem to have any significant
Notably, while there was no significant difference between any of the treatment groups
and the control, the mean background fluorescence did appear to be greater in the CMS and MS222 treatments than in to the control and 2-PE samples. This indicates that the basal stimulation
of these groups may in fact be elevated, which masks the stimulated results magnitude and thus
resulted in a lower SI value. This may mean that CMS and MS-222 may in fact stimulate the
immune response, which should be investigated in further studies. Also, a lethal dose of MS-222
was used to euthanize all the treatment and control groups. Though this may have acted as a
confounding variable, MS-222 was used in other studies as a means of euthanasia without
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noticeable interference with their results and the lack of noticeable suppression within the control
groups indicates that there was little interference within this study (6, 22). Furthermore, it
insured that the control group received the same euthanasia treatment, thus preventing any
variation between the control and treatment groups beyond the anesthetics.
5. Conclusion
In conclusion, MS-222, CMS, and 2-PE all suppressed the innate immune response of the
zebrafish kidney leukocytes, as reflected in signidicantly lower SI vlues compared to control
treatments. There was no significant difference in the level of suppression of the immune
response among the anesthetics, contrary to previous findings. Thus, CMS did not show any
significant difference from the established anesthetics.
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